Healthcare provider profile · identity verified

Cynthia A. Buchweitz, MD

Family Practice · EAST LANSING, MI · NPI 1003910753

Profile state: partd only Open Payments: 2025 Medicare Part D: 2024 Last identity check: 2026-08-10 Page data build: 2026-08-12

Verified facts

What the public records show

We did not find matching Open Payments records for this doctor in 2025.

These records do not establish that a payment influenced prescribing or medical care.

Payment overview · 2025

General Payments

We did not find matching Open Payments records for this doctor in the selected program year.

Separate record types

Research & Ownership

Research Payments (direct recipient): not present in the loaded data

Associated Research Funding (for example, named PI): not present in the loaded data

Ownership / Investment: not present in the loaded data

These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.

Analysis 1 · Payment-linked products

Products named in Open Payments records

No payment-linked product analysis is available because no matching General Payment records were found for the selected year.

Public prescribing for products named in payments

There is no explicit payment-product set available for a Part D comparison.

The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.

Analysis 2 · Same-company prescribing overlap

Drugs reported in other payments from the same company that also appear in Medicare Part D

This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.

There is no payer-company set available for this comparison.

These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.

Public Medicare Part D data

Provider-and-drug rows loaded for 2024

Brand	Generic	Claims	Beneficiaries
Levothyroxine Sodium	Levothyroxine Sodium	701	180
Atorvastatin Calcium	Atorvastatin Calcium	461	141
Amlodipine Besylate	Amlodipine Besylate	308	99
Lisinopril	Lisinopril	297	83
Omeprazole	Omeprazole	286	90
Hydrocodone-Acetaminophen	Hydrocodone/Acetaminophen	255	49
Rosuvastatin Calcium	Rosuvastatin Calcium	243	76
Metformin Hcl	Metformin Hcl	216	71
Losartan Potassium	Losartan Potassium	214	67
Montelukast Sodium	Montelukast Sodium	203	63
Metoprolol Succinate	Metoprolol Succinate	171	52
Gabapentin	Gabapentin	164	53
Pantoprazole Sodium	Pantoprazole Sodium	155	52
Simvastatin	Simvastatin	147	42
Trazodone Hcl	Trazodone Hcl	147	42
Escitalopram Oxalate	Escitalopram Oxalate	135	45
Fluticasone Propionate	Fluticasone Propionate	134	58
Duloxetine Hcl	Duloxetine Hcl	131	44
Meloxicam	Meloxicam	119	39
Alprazolam	Alprazolam	118	35
Potassium Chloride	Potassium Chloride	118	39
Ozempic	Semaglutide	111	21
Furosemide	Furosemide	108	33
Jardiance	Empagliflozin	107	38
Sertraline Hcl	Sertraline Hcl	98	28
Fluoxetine Hcl	Fluoxetine Hcl	95	27
Alendronate Sodium	Alendronate Sodium	94	31
Albuterol Sulfate Hfa	Albuterol Sulfate	93	59
Bupropion Xl	Bupropion Hcl	86	28
Clonazepam	Clonazepam	83	12
Zolpidem Tartrate	Zolpidem Tartrate	83	17
Carvedilol	Carvedilol	76	24
Tamsulosin Hcl	Tamsulosin Hcl	76	21
Trulicity	Dulaglutide	75	14
Lisinopril-Hydrochlorothiazide	Lisinopril/Hydrochlorothiazide	74	21
Estradiol	Estradiol	67	27
Lorazepam	Lorazepam	67	16
Citalopram Hbr	Citalopram Hydrobromide	63	16
Ezetimibe	Ezetimibe	63	18
Allopurinol	Allopurinol	61	20
Eliquis	Apixaban	59	14
Venlafaxine Hcl Er	Venlafaxine Hcl	59	16
Synthroid	Levothyroxine Sodium	58	13
Azithromycin	Azithromycin	54	46
Pravastatin Sodium	Pravastatin Sodium	53	15
Metoprolol Tartrate	Metoprolol Tartrate	52	13
Cyclobenzaprine Hcl	Cyclobenzaprine Hcl	51	20
Myrbetriq	Mirabegron	50	15
Pregabalin	Pregabalin	49	13
Bupropion Hcl Sr	Bupropion Hcl	46	12
Temazepam	Temazepam	43	suppressed
Ibuprofen	Ibuprofen	42	18
Januvia	Sitagliptin Phosphate	42	15
Spironolactone	Spironolactone	42	14
Triamterene-Hydrochlorothiazid	Triamterene/Hydrochlorothiazid	42	14
Hydrochlorothiazide	Hydrochlorothiazide	39	13
Donepezil Hcl	Donepezil Hcl	38	suppressed
Tramadol Hcl	Tramadol Hcl	38	12
Trelegy Ellipta	Fluticasone/Umeclidin/Vilanter	38	suppressed
Esomeprazole Magnesium	Esomeprazole Magnesium	37	suppressed
Azelastine Hcl	Azelastine Hcl	36	12
Fluticasone-Salmeterol	Fluticasone Propion/Salmeterol	35	12
Memantine Hcl	Memantine Hcl	35	suppressed
Diazepam	Diazepam	34	17
Prednisone	Prednisone	34	16
Losartan-Hydrochlorothiazide	Losartan/Hydrochlorothiazide	33	suppressed
Olmesartan Medoxomil	Olmesartan Medoxomil	32	suppressed
Valacyclovir	Valacyclovir Hcl	32	18
Oxybutynin Chloride Er	Oxybutynin Chloride	31	13
Verapamil Er	Verapamil Hcl	31	suppressed
Clonidine Hcl	Clonidine Hcl	30	suppressed
Glipizide Er	Glipizide	30	suppressed
Lansoprazole	Lansoprazole	30	suppressed
Xarelto	Rivaroxaban	30	suppressed
Betamethasone Diprop Augmented	Betamethasone/Propylene Glyc	29	21
Doxycycline Hyclate	Doxycycline Hyclate	29	21
Lantus Solostar	Insulin Glargine,hum.Rec.Anlog	28	suppressed
Ondansetron Odt	Ondansetron	28	15
Fluconazole	Fluconazole	27	19
Lidocaine	Lidocaine	27	11
Celecoxib	Celecoxib	26	11
Methocarbamol	Methocarbamol	26	suppressed
Rybelsus	Semaglutide	26	suppressed
Aripiprazole	Aripiprazole	25	suppressed
Amitriptyline Hcl	Amitriptyline Hcl	24	suppressed
Ropinirole Hcl	Ropinirole Hcl	24	suppressed
Diltiazem 24hr Er (Cd)	Diltiazem Hcl	23	suppressed
Fosinopril Sodium	Fosinopril Sodium	23	suppressed
Mirtazapine	Mirtazapine	23	suppressed
Morphine Sulfate	Morphine Sulfate	23	suppressed
Oxycodone-Acetaminophen	Oxycodone Hcl/Acetaminophen	23	suppressed
Advair Hfa	Fluticasone Propion/Salmeterol	21	suppressed
Atenolol	Atenolol	21	suppressed
Buspirone Hcl	Buspirone Hcl	21	suppressed
Clopidogrel	Clopidogrel Bisulfate	21	suppressed
Janumet	Sitagliptin Phos/Metformin Hcl	21	suppressed
Propranolol Hcl Er	Propranolol Hcl	21	suppressed
Baclofen	Baclofen	20	suppressed
Metformin Hcl Er	Metformin Hcl	20	suppressed
Paroxetine Hcl	Paroxetine Hcl	20	suppressed
Azelastine-Fluticasone	Azelastine/Fluticasone	19	suppressed
Dulera	Mometasone/Formoterol	19	suppressed
Levocetirizine Dihydrochloride	Levocetirizine Dihydrochloride	19	suppressed
Pioglitazone Hcl	Pioglitazone Hcl	19	suppressed
Solifenacin Succinate	Solifenacin Succinate	19	suppressed
Ciprofloxacin Hcl	Ciprofloxacin Hcl	18	suppressed
Famotidine	Famotidine	18	suppressed
Fenofibrate	Fenofibrate	18	suppressed
Butalbital-Acetaminophen-Caffe	Butalb/Acetaminophen/Caffeine	17	suppressed
Ipratropium Bromide	Ipratropium Bromide	17	suppressed
Sumatriptan Succinate	Sumatriptan Succinate	17	suppressed
Acyclovir	Acyclovir	16	suppressed
Fenofibrate	Fenofibrate Nanocrystallized	16	suppressed
Finasteride	Finasteride	16	suppressed
Levetiracetam	Levetiracetam	16	suppressed
Sulfamethoxazole-Trimethoprim	Sulfamethoxazole/Trimethoprim	16	14
Indapamide	Indapamide	15	suppressed
Mounjaro	Tirzepatide	15	suppressed
Symbicort	Budesonide/Formoterol Fumarate	15	suppressed
Alfuzosin Hcl Er	Alfuzosin Hcl	14	suppressed
Clobetasol Propionate	Clobetasol Propionate	14	11
Lactulose	Lactulose	14	suppressed
Linzess	Linaclotide	14	suppressed
Nadolol	Nadolol	14	suppressed
Nystatin	Nystatin	14	12
Risedronate Sodium	Risedronate Sodium	14	suppressed
Diclofenac Sodium	Diclofenac Sodium	13	suppressed
Ketoconazole	Ketoconazole	13	suppressed
Lamotrigine	Lamotrigine	13	suppressed
Lovastatin	Lovastatin	13	suppressed
Methylprednisolone	Methylprednisolone	13	11
Ultra-Fine Mini Pen Needle	Pen Needle, Diabetic	13	suppressed
Amoxicillin-Clavulanate Potass	Amoxicillin/Potassium Clav	12	12
Budesonide-Formoterol Fumarate	Budesonide/Formoterol Fumarate	12	suppressed
Ezetimibe-Simvastatin	Ezetimibe/Simvastatin	12	suppressed
Glimepiride	Glimepiride	12	suppressed
Isosorbide Mononitrate Er	Isosorbide Mononitrate	12	suppressed
Nortriptyline Hcl	Nortriptyline Hcl	12	suppressed
Tizanidine Hcl	Tizanidine Hcl	12	suppressed
Tramadol Hcl Er	Tramadol Hcl	12	suppressed
Triamcinolone Acetonide	Triamcinolone Acetonide	12	suppressed
Breo Ellipta	Fluticasone/Vilanterol	11	suppressed
Desvenlafaxine Succinate Er	Desvenlafaxine Succinate	11	suppressed
Hydralazine Hcl	Hydralazine Hcl	11	suppressed
Hydrocortisone	Hydrocortisone	11	suppressed
Mirabegron Er	Mirabegron	11	suppressed
Naproxen	Naproxen	11	suppressed
Quetiapine Fumarate	Quetiapine Fumarate	11	suppressed
Spiriva Handihaler	Tiotropium Bromide	11	suppressed

Timeline

Payment and prescribing data by year

Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.

Year	General Payments	Main payer	Explicit products	Company overlaps	Part D coverage
2025	—	—	—	—	—
2024	—	—	—	—	Complete

Questions to ask

Questions you could discuss with your doctor

Are there reasonable alternatives I should understand when we discuss treatment options?
How should I interpret the industry-payment records shown here in the context of my care?

These are general questions generated from reviewed templates. They are not personalized medical advice.

Sources and limitations

How to read this page

Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.

Loaded source releases

Dataset	Year	Publication	Source
CMS Open Payments — General Payments	2025	2026-06-30	Original source
Medicare Part D Prescribers by Provider and Drug	2024	2026-05-06	Original source
NPPES Data Dissemination V2	current / reference data	2026-08-10	Original source

Methodology version: 2.1

Editorial template version: 2.4

Product contract version: 2.0

Schema version: 0.7.0

Page data build: 2026-08-12T23:34:59.370714+00:00

Publication policy: eligible for indexing after public-launch controls are enabled

Full methodology · Questions & answers · Report a possible error